A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008954:Models, Biological; D010276:Parasympatholytics / Q000494:pharmacology*; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism; D010830:Physostigmine / Q000494:pharmacology; D011600:Psychopharmacology; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D011950:Receptors, Cholinergic; D011955:Receptors, Drug / Q000187:drug effects*; D014149:Tranquilizing Agents / Q000494:pharmacology*
D010276:Parasympatholytics; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D010830:Physostigmine; D000661:Amphetamine; D004298:Dopamine